Balance Sheet

Assets

+13%

-1%

10Y

Currency: JPY

	Mar-2002	Mar-2003	Mar-2004	Mar-2005	Mar-2006	Mar-2007	Mar-2008	Mar-2009	Mar-2010	Mar-2011	Mar-2012	Mar-2013	Mar-2014	Mar-2015	Mar-2016	Mar-2017	Mar-2018	Mar-2019	Mar-2020	Mar-2021	Mar-2022	Mar-2023	Mar-2024	Mar-2025
Assets
Cash & Cash Equivalents	30 671	36 864	38 220	35 858	37 187	33 480	12 067	16 801	22 644	23 115	19 234	23 937	31 266	27 241	25 666	27 109	24 371	26 325	36 329	20 456	30 013	25 893	22 894	25 169
Cash Equivalents	30 671	36 864	38 220	35 858	37 187	33 480	12 067	16 801	22 644	23 115	19 234	23 937	31 266	27 241	25 666	27 109	24 371	26 325	36 329	20 456	30 013	25 893	22 894	25 169
Short-Term Investments	13 602	11 582	13 201	14 583	20 237	14 142	33 881	26 362	26 097	27 500	26 600	27 344	27 048	25 132	24 476	21 039	23 288	23 039	23 342	23 998	23 139	23 706	23 039	23 485
Total Receivables	27 620	24 010	24 591	26 148	25 190	27 938	23 339	23 011	22 049	22 995	26 057	25 003	23 710	23 674	24 965	24 729	28 872	26 962	19 462	23 058	22 806	22 779	28 679	29 653
Accounts Receivables	27 620	24 010	24 591	26 148	25 190	27 938	23 339	23 011	22 049	22 995	26 057	25 003	23 710	23 674	24 965	24 729	28 872	26 962	19 462	23 058	22 806	22 779	28 679	29 516
Other Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	137
Inventory	7 198	8 377	8 728	9 797	12 662	10 876	10 118	10 323	8 529	11 009	9 962	11 122	12 812	14 646	17 375	16 724	15 932	13 963	13 438	20 118	18 987	22 798	26 296	24 979
Other Current Assets	11 885	8 667	8 899	7 356	7 187	7 282	6 150	5 529	6 317	5 227	4 935	4 856	6 058	6 668	7 569	7 617	5 700	5 493	4 106	5 335	4 397	5 465	3 643	3 694
Total Current Assets	90 976	89 500	93 639	93 742	102 463	93 718	85 555	82 026	85 636	89 846	86 788	92 262	100 894	97 361	100 051	97 218	98 163	95 782	96 677	92 965	99 342	100 641	104 551	106 980
PP&E Net	28 844	28 224	28 173	27 794	28 649	30 631	29 585	28 368	27 827	27 097	26 804	26 527	26 960	26 852	26 758	26 308	26 396	25 503	24 605	24 290	24 074	24 579	24 861	27 069
PP&E Gross	28 844	28 224	28 173	27 794	28 649	30 631	29 585	28 368	27 827	27 097	26 804	26 527	26 960	26 852	26 758	26 308	26 396	25 503	24 605	24 290	24 074	24 579	24 861	27 069
Accumulated Depreciation	22 345	23 756	25 394	26 601	28 795	30 412	32 533	34 593	34 996	36 351	37 344	38 493	39 404	38 362	38 751	39 342	40 728	41 992	43 365	44 105	44 138	44 205	44 926	44 777
Intangible Assets	2 912	2 690	2 656	3 835	3 592	3 861	3 099	2 250	1 809	1 378	953	818	692	785	813	1 845	1 716	1 519	1 511	1 640	1 569	1 507	1 683	1 652
Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	309	242
Note Receivable	0	0	1 682	1 627	655	615	593	493	377	157	137	122	137	134	0	119	98	118	36	14	3	5	5	5
Long-Term Investments	25 728	22 465	32 008	34 917	35 795	31 878	27 717	23 128	29 610	24 434	26 394	38 091	41 669	54 407	62 363	58 344	81 194	86 958	105 158	138 133	96 631	74 769	106 361	84 869
Other Long-Term Assets	7 271	8 695	4 678	3 023	2 955	2 876	4 005	3 906	1 756	3 330	3 309	2 208	2 297	1 945	3 245	2 967	3 254	3 642	3 807	11 819	16 468	19 699	23 159	23 242
Other Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	309	242
Total Assets	155 731 N/A	151 574 -3%	162 836 +7%	164 938 +1%	174 109 +6%	163 579 -6%	150 554 -8%	140 171 -7%	147 015 +5%	146 242 -1%	144 385 -1%	160 028 +11%	172 649 +8%	181 484 +5%	193 345 +7%	186 801 -3%	210 821 +13%	213 522 +1%	231 794 +9%	268 861 +16%	238 087 -11%	221 200 -7%	260 929 +18%	244 059 -6%
Liabilities
Accounts Payable	7 574	7 493	7 205	8 437	9 193	9 548	4 352	5 698	5 623	5 228	4 499	4 882	5 390	6 045	5 829	4 849	4 894	4 347	5 237	7 909	4 104	4 617	4 893	4 602
Accrued Liabilities	1 807	2 035	1 746	1 994	1 402	1 458	1 880	1 952	2 074	2 152	2 038	2 175	2 649	2 169	2 210	2 113	2 251	1 989	1 866	1 830	1 721	1 679	1 856	2 192
Short-Term Debt	0	0	0	0	0	0	0	0	0	0	0	1 880	1 760	1 730	1 730	1 730	1 730	1 730	1 730	1 730	1 640	1 490	1 340	1 280
Current Portion of Long-Term Debt	1 831	2 110	2 269	2 275	12 250	2 493	14 423	2 402	2 213	2 324	2 101	121	111	149	150	114	106	144	152	144	116	145	151	151
Other Current Liabilities	7 421	4 135	7 574	5 584	7 086	7 640	5 755	5 881	6 199	6 198	6 024	6 519	7 969	8 841	9 689	6 850	8 467	5 591	8 039	6 632	11 163	7 026	9 423	8 353
Total Current Liabilities	18 633	15 773	18 794	18 290	29 931	21 139	26 410	15 933	16 109	15 902	14 662	15 577	17 879	18 934	19 608	15 656	17 448	13 801	17 024	18 245	18 744	14 957	17 663	16 578
Long-Term Debt	22 367	22 032	21 957	21 916	12 299	12 273	403	841	1 294	1 768	1 547	1 525	1 409	1 614	1 591	1 732	2 097	2 201	386	304	227	317	236	166
Deferred Income Tax	0	0	0	0	2 493	2 027	0	0	168	0	0	3 100	3 817	7 338	7 395	5 645	9 935	11 388	17 191	28 480	16 259	10 426	21 188	16 481
Minority Interest	115	91	91	92	94	131	153	165	181	186	202	225	231	279	265	329	390	444	504	638	794	914	1 107	1 122
Other Liabilities	4 786	5 044	5 728	4 553	5 034	4 909	4 970	4 985	5 223	4 640	4 790	5 042	6 723	2 878	6 626	5 985	5 249	3 425	4 223	1 879	677	686	706	708
Total Liabilities	45 901 N/A	42 940 -6%	46 570 +8%	44 851 -4%	49 851 +11%	40 479 -19%	31 936 -21%	21 924 -31%	22 975 +5%	22 496 -2%	21 201 -6%	25 469 +20%	30 059 +18%	31 043 +3%	35 485 +14%	29 347 -17%	35 119 +20%	31 259 -11%	39 328 +26%	49 546 +26%	36 701 -26%	27 300 -26%	40 900 +50%	35 055 -14%
Equity
Common Stock	24 219	24 219	24 219	24 219	24 219	24 221	24 271	24 356	24 356	24 356	24 356	24 356	24 356	24 356	24 356	24 356	24 356	24 356	24 356	24 356	24 356	24 356	24 356	24 356
Retained Earnings	61 596	63 004	67 811	71 344	71 388	71 527	72 407	72 894	75 582	77 796	80 716	83 832	90 918	95 565	96 230	101 755	102 834	106 026	106 461	109 270	118 183	125 576	127 310	131 488
Additional Paid In Capital	24 110	24 110	24 110	24 111	24 112	24 114	24 164	24 253	24 254	24 254	24 254	24 254	24 254	24 254	24 247	24 226	24 226	24 226	24 226	24 226	24 226	24 226	24 226	24 226
Unrealized Security Profit/Loss	345	301	4 001	4 390	8 599	7 357	1 985	1 044	4 182	1 678	2 536	10 797	12 724	21 517	0	21 268	36 752	40 326	50 706	74 351	45 095	30 393	52 782	38 752
Treasury Stock	440	3 000	3 877	3 980	4 060	4 119	4 207	4 300	4 336	4 339	8 680	8 681	8 684	16 591	0	12 838	11 607	11 607	11 608	12 911	12 912	12 912	13 209	14 520
Other Equity	0	0	0	0	0	0	0	0	0	0	1	1	978	1 340	1 729	1 313	859	1 064	1 675	23	2 438	2 261	4 564	4 702
Total Equity	109 830 N/A	108 634 -1%	116 264 +7%	120 084 +3%	124 258 +3%	123 100 -1%	118 620 -4%	118 247 0%	124 038 +5%	123 745 0%	123 183 0%	134 559 +9%	142 590 +6%	150 441 +6%	157 860 +5%	157 454 0%	175 702 +12%	182 263 +4%	192 466 +6%	219 315 +14%	201 386 -8%	193 900 -4%	220 029 +13%	209 004 -5%
Total Liabilities & Equity	155 731 N/A	151 574 -3%	162 834 +7%	164 935 +1%	174 109 +6%	163 579 -6%	150 556 -8%	140 171 -7%	147 013 +5%	146 241 -1%	144 384 -1%	160 028 +11%	172 649 +8%	181 484 +5%	193 345 +7%	186 801 -3%	210 821 +13%	213 522 +1%	231 794 +9%	268 861 +16%	238 087 -11%	221 200 -7%	260 929 +18%	244 059 -6%
Shares Outstanding
Common Shares Outstanding	57	55	54	54	54	54	54	54	54	54	51	51	51	49	49	48	47	47	47	46	46	46	44	43

Income Statement Balance Sheet Cash Flow Statement

Kissei Pharmaceutical Co Ltd
TSE:4547

Balance Sheet

Balance Sheet Decomposition
Kissei Pharmaceutical Co Ltd

Balance Sheet
Kissei Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Kissei Pharmaceutical Co Ltd TSE:4547

Balance Sheet

Balance Sheet Decomposition Kissei Pharmaceutical Co Ltd

Balance Sheet Kissei Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Kissei Pharmaceutical Co Ltd
TSE:4547

Balance Sheet Decomposition
Kissei Pharmaceutical Co Ltd

Balance Sheet
Kissei Pharmaceutical Co Ltd